Residual thallium activity in persistent defects after tracer reinjection at rest
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Dokumenttyp: | Kapitel/Artikel Konferenzschrift |
| Sprache: | Englisch |
| Veröffentlicht: |
1995
|
| In: |
Radioactive isotopes in clinical medicine and research
Year: 1995, Pages: 137-142 |
| Online-Zugang: |
|
| Verfasserangaben: | Bernd Bubeck, Siegfried Hagl |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1893909425 | ||
| 003 | DE-627 | ||
| 005 | 20250616105248.0 | ||
| 007 | tu | ||
| 008 | 240704s1995 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)1893909425 | ||
| 035 | |a (DE-599)KXP1893909425 | ||
| 035 | |a (OCoLC)1475301473 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Bubeck, Bernd |d 1949- |e VerfasserIn |0 (DE-588)1067692207 |0 (DE-627)819091502 |0 (DE-576)426855493 |4 aut | |
| 245 | 1 | 0 | |a Residual thallium activity in persistent defects after tracer reinjection at rest |c Bernd Bubeck, Siegfried Hagl |
| 264 | 1 | |c 1995 | |
| 300 | |a 6 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Hagl, Siegfried |e VerfasserIn |0 (DE-588)1076770274 |0 (DE-627)835318354 |0 (DE-576)445655224 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Radioactive isotopes in clinical medicine and research |d Basel [u.a.] : Birkhäuser, 1995 |g (1995), Seite 137-142 |h XVIII, 450 S. |w (DE-627)172750369 |w (DE-576)045089140 |z 3764350822 |z 0817650822 |7 nnam |a Residual thallium activity in persistent defects after tracer reinjection at rest |
| 773 | 1 | 8 | |g year:1995 |g pages:137-142 |g extent:6 |a Residual thallium activity in persistent defects after tracer reinjection at rest |
| 951 | |a AR | ||
| 992 | |a 20240704 | ||
| 993 | |a ConferencePaper | ||
| 994 | |a 1995 | ||
| 998 | |g 1076770274 |a Hagl, Siegfried |m 1076770274:Hagl, Siegfried |d 910000 |d 910200 |e 910000PH1076770274 |e 910200PH1076770274 |k 0/910000/ |k 1/910000/910200/ |p 2 |y j | ||
| 998 | |g 1067692207 |a Bubeck, Bernd |m 1067692207:Bubeck, Bernd |d 50000 |e 50000PB1067692207 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1893909425 |e 4546672217 | ||
| BIB | |a Y | ||
| JSO | |a {"language":["eng"],"relHost":[{"name":{"displayForm":["ed. by H. Bergmann; H. Sinzinger"]},"id":{"eki":["172750369"],"isbn":["3764350822","0817650822"]},"origin":[{"dateIssuedDisp":"1995","publisher":"Birkhäuser","dateIssuedKey":"1995","publisherPlace":"Basel [u.a.]"}],"physDesc":[{"noteIll":"Ill., graph. Darst.","noteFormat":"24 cm","extent":"XVIII, 450 S."}],"person":[{"role":"edt","display":"Bergmann, Helmar","roleDisplay":"Hrsg.","given":"Helmar","family":"Bergmann"}],"title":[{"title_sort":"Radioactive isotopes in clinical medicine and research","title":"Radioactive isotopes in clinical medicine and research","subtitle":"[21. Badgastein Symposium Radioactive Isotopes in Clinical Medicine and Research]"}],"language":["eng"],"corporate":[{"role":"oth","display":"Badgastein Symposium Radioactive Isotopes in Clinical Medicine and Research (21, 1994, Badgastein)"}],"recId":"172750369","type":{"bibl":"edited-book"},"disp":"Residual thallium activity in persistent defects after tracer reinjection at restRadioactive isotopes in clinical medicine and research","note":["Literaturangaben"],"part":{"text":"(1995), Seite 137-142","extent":"6","year":"1995","pages":"137-142"}}],"recId":"1893909425","physDesc":[{"extent":"6 S."}],"type":{"bibl":"chapter"},"person":[{"role":"aut","display":"Bubeck, Bernd","roleDisplay":"VerfasserIn","given":"Bernd","family":"Bubeck"},{"family":"Hagl","given":"Siegfried","roleDisplay":"VerfasserIn","display":"Hagl, Siegfried","role":"aut"}],"name":{"displayForm":["Bernd Bubeck, Siegfried Hagl"]},"id":{"eki":["1893909425"]},"origin":[{"dateIssuedDisp":"1995","dateIssuedKey":"1995"}],"title":[{"title_sort":"Residual thallium activity in persistent defects after tracer reinjection at rest","title":"Residual thallium activity in persistent defects after tracer reinjection at rest"}]} | ||
| SRT | |a BUBECKBERNRESIDUALTH1995 | ||